TMCnet News
Research and Markets: Updated Spinal Muscular Atrophy (SMA) Pipeline InsightsResearch and Markets (http://www.researchandmarkets.com/research/txcvqf/spinal_muscular) has announced the addition of the "Spinal Muscular Atrophy (SMA)-Pipeline Insights" report to their offering. Spinal Muscular Atrophy (SMA (News - Alert))- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Spinal Muscular Atrophy (SMA). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Spinal Muscular Atrophy (SMA) Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. Spinal Muscular Atrophy (SMA)- Pipeline Insighs Report covers the Spinal Muscular Atrophy (SMA) pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides Spinal Muscular Atrophy (SMA) related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in pipeline for Spinal Muscular Atrophy (SMA). Scope - The report provides a Spinal Muscular Atrophy (SMA) Landscape across the globe - The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information - Coverage of the Spinal Muscular Atrophy (SMA) pipeline on the basis of target, MOA, route of administration, technology involved and molecule type - The report reviews key players involved in the therapeutics development for Spinal Muscular Atrophy (SMA) and also provide company profiling - Pipeline products coverage based on various stages of development from NDA filings to discovery. - Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type For more information visit http://www.researchandmarkets.com/research/txcvqf/spinal_muscular
View source version on businesswire.com: http://www.businesswire.com/news/home/20150612005597/en/ |
